vimarsana.com

Page 6 - சீஎபேர்த வில்லியம்ஸ் ஶ்யாஂக் இணை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock

Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today the pricing of its previously announced underwritten public offering of 14,000,000 shares of common stock at a public offering price of $25.00 per share. The gross proceeds to Cerevel of the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $350 million. The offering is expected to close on July 7, 2021, subject to customary closing conditions. In addition, Cerevel has granted the underwriters a 30-day option to purchase an additional 2,100,000 shares of its common stock, at the public offering price, less underwriting discounts and commissions.

LegalZoom Announces Pricing of Initial Public Offering

Share: LegalZoom.com, Inc. ( LegalZoom ), today announced the pricing of its initial public offering of an aggregate of 19,121,000 shares of common stock at a price to the public of $28.00 per share. In addition, LegalZoom has granted the underwriters a 30-day option to purchase up to an additional 2,868,150 shares of its common stock at the public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on June 30, 2021 under the symbol LZ and the offering is expected to close on July 2, 2021, subject to customary closing conditions. J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Barclays Capital Inc. are acting as lead book-running managers for the proposed offering. BofA Securities, Inc., Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and Jefferies LLC are acting as book-running managers for the proposed offering. JMP Securities LLC, Raymond James & Associates, Inc., W

Integral Ad Science Announces Pricing of Initial Public Offering

Integral Ad Science Announces Pricing of Initial Public Offering News provided by Share this article Share this article NEW YORK, June 29, 2021 /PRNewswire/ Integral Ad Science ( IAS ), a global leader in digital media quality, today announced the pricing of its initial public offering of 15,000,000 shares of common stock at a price of $18 per share. The underwriters have a 30-day option to purchase up to an additional 2,250,000 shares of common stock from IAS. The shares of common stock are expected to begin trading on the Nasdaq Stock Market under the ticker symbol IAS on June 30, 2021. The offering is expected to close on July 2, 2021, subject to the satisfaction of customary closing conditions. 

New issues reprice lower, secondary holds levels steady

New issues reprice lower, secondary holds levels steady
bondbuyer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bondbuyer.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.